Related Experiment Video

Updated: Jul 25, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.1K

Hepatitis B screening to reduce liver cancer burden

C C Zhong1,2, W Xu3,4, J Huang1,2,5

  • 1The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|December 29, 2024
PubMed
Summary

No abstract available in PubMed .

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.1K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.0K

Related Experiment Videos

Last Updated: Jul 25, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.1K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.1K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.0K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Articles linked to this work by shared authors, journal, and citation graph.

Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor.

Journal of pediatric surgery·2000

Effect of allelic heterogeneity on the power of the transmission disequilibrium test.

Genetic epidemiology·2000

The components of an inorganic physiological buffer for Penaeus chinensis.

Methods in cell science : an official journal of the Society for In Vitro Biology·2000

Spatio-temporal tracking of myocardial deformations with a 4-D B-spline model from tagged MRI.

IEEE transactions on medical imaging·2000

An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing.

Cell·2000

Asbestos content in the lymph nodes of nonoccupationally exposed individuals.

American journal of industrial medicine·1999

A predictive model of survival in early-stage medullary breast carcinoma: a population-based study.

Hong Kong medical journal = Xianggang yi xue za zhi·2026

One-stop virtual planning for optimising implant selection and surgical efficiency in subtrochanteric fractures.

Hong Kong medical journal = Xianggang yi xue za zhi·2026

Trends and outcomes of massive primary postpartum haemorrhage and second-line therapy use: a retrospective study in a Hong Kong public hospital using the Hospital Authority electronic audit form.

Hong Kong medical journal = Xianggang yi xue za zhi·2026

Mid-term risk factor analysis and predictors of restenosis in patients undergoing carotid artery stenting.

Hong Kong medical journal = Xianggang yi xue za zhi·2026

Kidney health for all: caring for people, protecting the planet.

Hong Kong medical journal = Xianggang yi xue za zhi·2026

Functional outcomes following mechanical thrombectomy beyond 6 hours after acute ischaemic stroke.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us